As of June 2026, 1 paid clinical trial is testing Mammography in Lynchburg, Virginia. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Lynchburg has approximately 54 recruiting research studies across a wide range of therapeutic areas. Virginia hosts the University of Virginia Health System, VCU Health, and Inova Health System, running clinical trials across oncology, cardiology, and neuroscience.
Researchers run research studies in Lynchburg, VA at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Centra Alan B Pearson Regional Cancer Center | Lung Non-Small Cell Carcinoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 14 |
| Piedmont Eye Center | Diabetic Macular Edema, Geographic Atrophy, Age-related Macular Degeneration (AMD) | 10 |
| Blue Ridge Medical Research | Colitis, Ulcerative, Crohn Disease, Eosinophilic Esophagitis | 3 |
| Centra Health, Inc. dba Stroobants Cardiovascular Center | Heart Failure, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | 2 |
| Piedmont Eye Center, Inc. | Dry Eye Disease (DED), Geographic Atrophy, Macular Degeneration | 2 |
| Stroobants Cardiovascular Center | Peripheral Arterial Disease, Severe Hypertriglyceridemia | 2 |
| Adverum Clinical Site 199 | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Alan B. Pearson Regional Cancer Center | Breast Cancer | 1 |
| Blue Ridge Medical Research - Gastroenterology Associates of Central Virginia | Moderately to Severely Active Crohns Disease | 1 |
| Blue Ridge Medical Research - Site Number: 8400020 | Ulcerative Colitis | 1 |
| Blue Ridge Medical Research: 8400020 | Crohn's Disease | 1 |
| Centra Health dba Stroobants Cardiovascular Center | Hypertension, Hypertension, Essential, Hypertension, Systolic | 1 |
| Centra Health, Inc.dba Stroobants Cardiovascular Center | Paroxysmal Atrial Fibrillation | 1 |
| Centra Medical Group Stroobants Cardiovascular Center | Atrial Fibrillation (AF), Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation | 1 |
| Dr. Falk Investigational Site | Eosinophilic Esophagitis | 1 |
| Gastroenterology Associates of Central Virginia | Crohn's Disease, Inflammatory Bowel Diseases | 1 |
| Piedmont Eye Center (Site 054) | Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration | 1 |
| Piedmont Eye Center /ID# 256386 | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
| Piedmont Eye Center /ID# 267929 | Dry Eye Disease | 1 |
| Surgery Center of Lynchburg | Lumbar Spinal Stenosis | 1 |
| The Education & Research Foundation, Inc. /ID# 254852 | Hidradenitis Suppurativa | 1 |
| The Education & Research Foundation- Site Number : 8400036 | Acne | 1 |
| Vanda Investigational Site | Dry Eye | 1 |
| Womens Health Services of Central Virginia | Endometriosis | 1 |
Recruiting trials in Lynchburg grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Virginia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Virginia research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Lynchburg from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 54 recruiting clinical trials in Lynchburg, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Lynchburg compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Lynchburg include Breast Cancer (3), Diabetic Macular Edema (3), Geographic Atrophy (3), Lung Non-Small Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lynchburg on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Lynchburg include Centra Alan B Pearson Regional Cancer Center, Piedmont Eye Center, Blue Ridge Medical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Lynchburg are Cancer & tumors (16), Eye & vision (15), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.